Storia in 5 fonti

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress to stage 4.

Raccontata da

giovedì 21 maggio 2026·healio.com
GLP-1s demonstrate ‘large’ & ‘consistent’ protective effects against cancer metastases
CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual…
giovedì 21 maggio 2026·medpagetoday.com
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types
Accumulating evidence of possible benefit warrants randomized trials, experts say

giovedì 21 maggio 2026·

lastampa.it

I farmaci anti-obesità potrebbero ridurre il rischio di metastasi in quattro tumori

Gli analoghi di Glp-1 sembrano prevenire la progressione delle neoplasie verso lo stadio metastatico nei pazienti diabetici. Lo rivela uno studio presentato du…

giovedì 21 maggio 2026·

nbcnews.com

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress to stage 4.

venerdì 22 maggio 2026·

independent.co.uk

GLP-1 drugs may result in better outcomes for cancer patients, study claims

GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers

GLP-1s demonstrate ‘large’ & ‘consistent’ protective effects against cancer metastases

GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

I farmaci anti-obesità potrebbero ridurre il rischio di metastasi in quattro tumori

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

GLP-1 drugs may result in better outcomes for cancer patients, study claims